325 related articles for article (PubMed ID: 8638832)
1. Long-term angiotensin-converting enzyme inhibitor treatment attenuates adrenergic responsiveness without altering hemodynamic control in patients undergoing cardiac surgery.
Licker M; Neidhart P; Lustenberger S; Valloton MB; Kalonji T; Fathi M; Morel DR
Anesthesiology; 1996 Apr; 84(4):789-800. PubMed ID: 8638832
[TBL] [Abstract][Full Text] [Related]
2. Effects of chronic angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor treatments on neurohormonal levels and haemodynamics during cardiopulmonary bypass.
Oh YJ; Lee JH; Nam SB; Shim JK; Song JH; Kwak YL
Br J Anaesth; 2006 Dec; 97(6):792-8. PubMed ID: 17032660
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibition and smoking potentiate the kinin response to cardiopulmonary bypass.
Pretorius M; McFarlane JA; Vaughan DE; Brown NJ; Murphey LJ
Clin Pharmacol Ther; 2004 Oct; 76(4):379-87. PubMed ID: 15470338
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass.
Tuman KJ; McCarthy RJ; O'Connor CJ; Holm WE; Ivankovich AD
Anesth Analg; 1995 Mar; 80(3):473-9. PubMed ID: 7864410
[TBL] [Abstract][Full Text] [Related]
5. ACE inhibition does not exaggerate the blood pressure decrease in the early phase of spinal anaesthesia.
Höhne C; Meier L; Boemke W; Kaczmarczyk G
Acta Anaesthesiol Scand; 2003 Aug; 47(7):891-6. PubMed ID: 12859312
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
[TBL] [Abstract][Full Text] [Related]
7. ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock.
Leisman DE; Handisides DR; Busse LW; Chappell MC; Chawla LS; Filbin MR; Goldberg MB; Ham KR; Khanna AK; Ostermann M; McCurdy MT; Adams CD; Hodges TN; Bellomo R;
Crit Care; 2024 Apr; 28(1):130. PubMed ID: 38637829
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibition alters the fibrinolytic response to cardiopulmonary bypass.
Pretorius M; Murphey LJ; McFarlane JA; Vaughan DE; Brown NJ
Circulation; 2003 Dec; 108(25):3079-83. PubMed ID: 14656921
[TBL] [Abstract][Full Text] [Related]
9. Chronic angiotensin converting inhibition does not influence renal hemodynamic and function during cardiac surgery.
Licker M; Schweizer A; Höhn L; Morel DR
Can J Anaesth; 1999 Jul; 46(7):626-34. PubMed ID: 10442956
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns.
Krombach RS; Clair MJ; Hendrick JW; Houck WV; Zellner JL; Kribbs SB; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
Cardiovasc Res; 1998 Jun; 38(3):631-45. PubMed ID: 9747431
[TBL] [Abstract][Full Text] [Related]
11. Effects of angiotensin converting enzyme inhibition on systemic vascular resistance and vasoconstrictor requirements during hypothermic cardiopulmonary bypass.
Deakin CD; Dalrymple-Hay MJ; Jones P; Monro JL
Eur J Cardiothorac Surg; 1998 May; 13(5):546-50. PubMed ID: 9663536
[TBL] [Abstract][Full Text] [Related]
12. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
[TBL] [Abstract][Full Text] [Related]
13. Post-perfusion syndrome and disturbed microcirculation after cardiac surgery: the role of angiotensin-converting-enzyme inhibitors.
Boeken U; Feindt P; Mohan E; Zimmermann N; Micek M; Kalweit G; Gams E
Thorac Cardiovasc Surg; 1999 Dec; 47(6):347-51. PubMed ID: 10670790
[TBL] [Abstract][Full Text] [Related]
14. Haemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischaemic heart dysfunction.
Ryckwaert F; Colson P; Ribstein J; Boccara G; Guillon G
Br J Anaesth; 2001 Feb; 86(2):169-75. PubMed ID: 11573655
[TBL] [Abstract][Full Text] [Related]
15. Terlipressin versus norepinephrine to counteract anesthesia-induced hypotension in patients treated with renin-angiotensin system inhibitors: effects on systemic and regional hemodynamics.
Morelli A; Tritapepe L; Rocco M; Conti G; Orecchioni A; De Gaetano A; Picchini U; Pelaia P; Reale C; Pietropaoli P
Anesthesiology; 2005 Jan; 102(1):12-9. PubMed ID: 15618781
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic vasopressin in patients receiving the angiotensin-converting enzyme inhibitor ramipril undergoing coronary artery bypass graft surgery.
Hasija S; Makhija N; Choudhury M; Hote M; Chauhan S; Kiran U
J Cardiothorac Vasc Anesth; 2010 Apr; 24(2):230-8. PubMed ID: 19875309
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of anesthesia in patients chronically treated with angiotensin-converting enzyme inhibitors.
Colson P; Saussine M; Séguin JR; Cuchet D; Chaptal PA; Roquefeuil B
Anesth Analg; 1992 Jun; 74(6):805-8. PubMed ID: 1595911
[TBL] [Abstract][Full Text] [Related]
18. alpha 1-Adrenergic responsiveness during coronary artery bypass surgery: effect of preoperative ejection fraction.
Schwinn DA; McIntyre RW; Hawkins ED; Kates RA; Reves JG
Anesthesiology; 1988 Aug; 69(2):206-17. PubMed ID: 2841891
[TBL] [Abstract][Full Text] [Related]
19. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.
Ruzicka M; Yuan B; Harmsen E; Leenen FH
Circulation; 1993 Mar; 87(3):921-30. PubMed ID: 8443912
[TBL] [Abstract][Full Text] [Related]
20. The effect of intravenous quinaprilat on plasma cytokines and hemodynamic variables during cardiac surgery.
Kwapisz MM; Müller M; Schindler E; Demir S; Veit M; Roth P; Hempelmann G
J Cardiothorac Vasc Anesth; 2004 Feb; 18(1):53-8. PubMed ID: 14973800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
